Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by TommyNickelson Oct 10, 2024 5:48am
141 Views
Post# 36260408

RE:RE:Let's say BTD is a given

RE:RE:Let's say BTD is a given From a Dec 2023 video, Roger said he expected to file a pre-BTD in Q1. That a response to this is "2 to 3 weeks". He went on to say that if there are no issues to address, a formal BTD would be filed in the same quarter. FDA response time is 60 days.

Obviously there was a delay as the pre-BTD just got filed. My guess is that the "events had to be addressed with 3rd party validation, which has happened.

We now have an additional 8 months of data. 

I read that 20 to 25 patients were needed for BTD. We now have 68 at the 90-day mark. 75 in total.

I would assume the BTD application is already filled out. Adjustments will be made based on the response to pre-BTD.

If we are lucky, a formal BTD is filed by the end of the month.
<< Previous
Bullboard Posts
Next >>